Akso Health Group
AHG
$1.71
-$0.03-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 415.75% | 415.75% | 675.98% | 675.98% | 14.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 415.75% | 415.75% | 675.98% | 675.98% | 14.83% |
| Cost of Revenue | 478.67% | 478.67% | 688.65% | 688.65% | 21.67% |
| Gross Profit | -668.59% | -668.59% | 396.91% | 396.91% | -41.76% |
| SG&A Expenses | -54.60% | -54.60% | -68.85% | -68.85% | -54.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.13% | 43.13% | 132.91% | 132.91% | -48.98% |
| Operating Income | 46.50% | 46.50% | 76.65% | 76.65% | 54.99% |
| Income Before Tax | -2,638.33% | -2,638.33% | 83.08% | 83.08% | 58.89% |
| Income Tax Expenses | -15,420,100.00% | -15,420,100.00% | 57.26% | 57.26% | -96.55% |
| Earnings from Continuing Operations | -2,128.84% | -2,128.84% | 81.96% | 81.96% | 58.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.05% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 800.00% | 800.00% | -5,533.33% | -5,533.33% | 160.58% |
| Net Income | -2,139.40% | -2,139.40% | 83.03% | 83.03% | -176.53% |
| EBIT | 46.50% | 46.50% | 76.65% | 76.65% | 54.99% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -374.52% | -374.52% | 98.28% | 98.28% | 11.58% |
| Normalized Basic EPS | 91.19% | 91.19% | 98.07% | 98.07% | 87.16% |
| EPS Diluted | -320.17% | -320.17% | 98.28% | 98.28% | 14.41% |
| Normalized Diluted EPS | 91.19% | 91.19% | 98.07% | 98.07% | 87.16% |
| Average Basic Shares Outstanding | 371.72% | 371.72% | 919.05% | 919.05% | 212.60% |
| Average Diluted Shares Outstanding | 371.72% | 371.72% | 919.05% | 919.05% | 212.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |